Intensified Competition and Price Competition in the CRO Industry
First written in FY2016. 4 of 6 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2026: 31 of 90 companies on the "Worse" side.
122 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「If competition intensifies, or contracted service prices decline, as a result of the expansion of the Japanese operations of global CROs from Europe and the United States and the low-price strategies of other CROs, the Group's performance could be affected by a decline in the number of contracts or contracted service prices.」
The risks of competition and price declines arising from the entry of global CROs from Europe and the United States into Japan and low-price strategies continue to be disclosed. - FY2021-Q2WorsenedAnnual report
「The CRO (Contract Research Organization) industry to which the Group belongs is also affected by revisions to pharmaceutical companies' research and development plans, resulting in a severe competitive environment in which multiple companies compete for a limited number of development projects.」
In addition to the previous price competition driven by low-price strategies, the number of available projects became limited as development plans were revised, intensifying competition among multiple companies. - FY2020RestatedAnnual report
「If the increase in CROs with business models similar to that of the Group, or intensified price competition resulting from the low-price strategies of CROs that are difficult to differentiate, causes contracted service prices to decline, the Group's performance could be affected.」
The risks of price competition and lower contracted service prices resulting from an increase in CROs with similar business models and low-price strategies continue. - FY2018RestatedAnnual report
「If the increase in CROs with business models similar to that of the Group, or intensified price competition resulting from the low-price strategies of CROs that are difficult to differentiate, causes contracted service prices to decline, the Group's performance could be affected.」
The risks of price competition and lower contracted service prices resulting from an increase in CROs with similar business models and low-price strategies continue. - FY2017RestatedAnnual report
「If the increase in CROs with business models similar to that of the Group, or intensified price competition resulting from the low-price strategies of CROs that are difficult to differentiate, causes contracted service prices to decline, the Group's performance could be affected.」
The risks of price competition and lower contracted service prices resulting from an increase in CROs with similar business models and low-price strategies continue. - FY2016First statedAnnual report
「If the increase in CROs with business models similar to that of the Group, or intensified price competition resulting from the low-price strategies of CROs that are difficult to differentiate, causes contracted service prices to decline, the Group's performance could be affected.」
The increase in CROs with similar business models and low-price strategies are identified as competitive risks that could lead to lower contracted service prices.